Wikisage, the free encyclopedia of the second generation, is digital heritage

Epilepsy: Difference between revisions

From Wikisage
Jump to navigation Jump to search
m (rfz)
Line 15: Line 15:
<ref>http://www.who.int/mediacentre/factsheets/fs999/en/</ref>
<ref>http://www.who.int/mediacentre/factsheets/fs999/en/</ref>
<ref>https://www.ligaepilepsia.cl/epilepsias/tipos-de-epilepsia</ref>
<ref>https://www.ligaepilepsia.cl/epilepsias/tipos-de-epilepsia</ref>
[http://www.ilae.org/Visitors/Publications/documents/ED_Arzimanoglou_2013.pdf A new perspective forEpileptic Disorders]
[http://www.ilae.org/Visitors/Publications/documents/ED_Arzimanoglou_2013.pdf A new perspective for Epileptic Disorders]
 
==Links==
==Links==
[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2007.01414.x/pdf Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population]
[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2007.01414.x/pdf Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population]

Revision as of 16:43, 25 July 2015

Classification of ethiology could divided in four categories:

  • idiopathic epilepsy
  • symptomatic epilepsy
  • provoked epilepsy
  • cryptogenic epilepsy

[1] It is difficult to distinguish between genetic and cryptogenic syndromes.

Morbility data is difficult to interpret when WHO states 50 millions persons affect by epilepsy[2]

nonadherence appears to be associated with increased health care costs,nevertheless XR-medicine appears as strategy to overcome compliance AED [3]

ILAE Classification

[4] [5] A new perspective for Epileptic Disorders

Links

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population Dravet's syndrome

References

References: